Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Yale School of Medicine](/img/noimage_org.png)
Yale School of Medicine
New Haven, Estados UnidosPublicacións en colaboración con investigadores/as de Yale School of Medicine (5)
2024
-
The Increased Burden of Rare Variants in Four Matrix Metalloproteinase-Related Genes in Childhood Glaucoma Suggests a Complex Genetic Inheritance of the Disease
International Journal of Molecular Sciences, Vol. 25, Núm. 11
2020
-
CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix
Human Genetics, Vol. 139, Núm. 10, pp. 1209-1231
-
Role of guca1c in primary congenital glaucoma and in the retina: Functional evaluation in zebrafish
Genes, Vol. 11, Núm. 5
2017
2011
-
WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: Analysis of gene-gene interactions
Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 11, pp. 8467-8478